China SXT Pharmaceuticals
NASDAQ: SXTC
Healthcare
Drug Manufacturers - Specialty & Generic
Rank
#32081
Market Cap
31.10 M
Volume
196,840
Price
2.26
Change (%)
1.80%
Country or region
China
China
China SXT Pharmaceuticals Stock Split History Overview
This company has undergone a total of 4 stock splits throughout its history. 4 reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on February 25, 2025 with a ratio of 1-for-8. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
China SXT Pharmaceuticals (NASDAQ: SXTC) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| February 25, 2025 | 1:8 | x0.125 | x6.25E-05 | Reverse |
| October 5, 2023 | 1:25 | x0.04 | x0.0005 | Reverse |
| May 19, 2022 | 1:20 | x0.05 | x0.0125 | Reverse |
| February 22, 2021 | 1:4 | x0.25 | x0.25 | Reverse |
Frequently Asked Questions
If China SXT Pharmaceuticals (stock symbol: NASDAQ: SXTC) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-8) that occurred on February 25, 2025.
China SXT Pharmaceuticals (stock symbol: NASDAQ: SXTC) has undergone a total of 4 stock splits. The most recent split occurred on February 25, 2025. One share bought prior to the first split on February 22, 2021 would now equal 0.00 shares.
China SXT Pharmaceuticals (stock symbol: NASDAQ: SXTC) has undergone 4 stock splits in its history. The most recent split, a 1-for-4 split, occurred on February 25, 2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.
